This inventor holds 6 USPTO granted patents and 3 published patent applications. Top assignees: Alembic Pharmaceuticals Limited, Dr. Reddy's Laboratories, Incorporated. Active years: 2003-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hyderabad, IN (2003 - 2019)
- Vadodara, IN (2019 - 2023)
Company Filing History:
4 out of 9 
2 out of 187 
Years Active: 2003-2023
Title: Mahender Rao Siripragada: Innovator in Pharmaceutical Patents
Introduction
Mahender Rao Siripragada is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid-state forms of drugs. With a total of 6 patents to his name, he has established himself as a key figure in pharmaceutical innovation.
Latest Patents
His latest patents include the invention of solid-state forms of Venetoclax and the processes for their preparation. The present invention provides solid-state forms of Venetoclax, particularly relating to novel alkali metal salt and/or DMF solvate forms of Venetoclax or its salt. This invention also encompasses the process for the preparation of Venetoclax using the said solid-state form.
Career Highlights
Throughout his career, Mahender has worked with prominent companies in the pharmaceutical industry, including Alembic Pharmaceuticals Limited and Dr. Reddy's Laboratories, Incorporated. His work has significantly impacted the development of new pharmaceutical formulations and processes.
Collaborations
Some of his notable coworkers include Tejas Shah and Chetan Patil. Their collaboration has contributed to the advancement of innovative solutions in the pharmaceutical sector.
Conclusion
Mahender Rao Siripragada's contributions to pharmaceutical patents highlight his expertise and dedication to innovation in drug development. His work continues to influence the industry and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile